We have identified a noncollagenous protein, Col3alt, encoded by an alternative transcript of the chick type III collagen gene; its amino acid sequence is out of frame with the collagen coding sequence. This 178-amino-acid protein is unique and has no recognizable motifs other than a hydrophobic domain. Col3alt is found in embryonic cartilage, muscle and bone and in the proliferative and prehypertrophic zones of juvenile chicken growth plates. The protein is intracellular in immature chondrocytes and myoblasts, but is extracellular in well-differentiated cartilage, muscle and bone, despite the lack of a conventional signal peptide. These results demonstrate an unexpected economy of genome utilization in which a single gene, using alternative promoters, gives rise to two unrelated proteins, type III collagen and Col3alt. q
Results and discussion
The chick type III collagen gene contains an internal promoter located in intron 23 (Zhang et al., 1997) . Transcription from this promoter gives rise to an alternative transcript containing exons 23A and 24-52 ( Fig. 1A) (Nah et al., 1994) . The alternative transcript contains several potential open reading frames: ORF2 contains the C-terminal two-thirds of the collagen sequence; ORFs 1 and 3 are out of frame with the collagen sequence. Translatability of the alternative transcript was tested in vitro using a cDNA template containing exons 23A-39. An RNA in the sense orientation was translated to produce a single ,23 kDa protein, consistent with the predicted size of ORF3 (Fig.  1B, lane 2) . Products the size of ORF1 and truncated ORF2 were not detected. No product was detected upon translation of the antisense RNA (Fig. 1B, lane 1) .
Antibodies were prepared against two synthetic peptides of the ORF3 sequence (Fig. 1C) , to determine whether this protein is a product of the alternative transcript. Both antibodies recognized recombinant ORF3 protein synthesized in Escherichia coli (Fig. 1D, lanes 1,3) . Antibody recognition of this protein was abolished by competition with appropriate peptides (Fig. 1D, lanes 2,4) . The antibodies were then used to identify the protein product of ORF3 in cultured chondrocytes, which contain the alternative transcript (Nah et al., 1994) . Western blotting, immunoprecipitation and immunofluorescence showed that both antibodies recognize a protein of the appropriate size in these cells (Fig. 1D , lanes 5,6; E). No protein was detected in cultured fibroblasts (Fig. 1E) , which contain type III collagen mRNA, but not the alternative transcript (Nah et al., 1994) .
Col3alt is found in all embryonic growth cartilages (red fluorescence in Fig. 2A-F ) and in perichondrium (stars in Fig. 2D,F) . It is predominantly intracellular early in cartilage development ( Fig. 2A,D ), but at later stages is found in the extracellular matrix (Fig. 2B ,E,F). Col3alt persists in the growth plate of post-embryonic cartilages, in the extracellular matrix throughout the proliferative and prehypertrophic zones (Fig. 2G ). It is largely absent from the hypertrophic zone, delineated by distribution of type X collagen (Schmid and Linsenmayer, 1985) (Fig. 2J) . A similar, although more intense, pattern is displayed by type II collagen, the major collagen of cartilage (Fig. 2H ). However, a few hypertrophic cells appear to retain intracellular Col3alt (Fig. 2J ). Col3alt is also present in unidentified material in vascular channels (enclosed by dashed line in Fig. 2G,J) .
The extracellular matrices of intramembranous ( Fig. 2K ) and endochondral bone (Fig. 2L ) also contain Col3alt.
Preincubation with peptide or omission of primary antibody reduced staining to background levels (Fig. 2M,N) . Skeletal muscle (Fig. 2O-Q) and smooth muscle surrounding blood vessels (Fig. 2R ) also contain Col3alt. Similar to embryonic cartilages, at early stages of muscle development Col3alt is predominantly intracellular, while at later stages it is found in the extracellular matrix (compare Fig. 2O ,Q), suggesting that its secretion is developmentally regulated. Ongoing gain-of-function studies should clarify Col3alt roles in development and in tissue structure and function.
Two observations indicate that Col3alt is regulated independently of type III collagen. First, Col3alt is found in embryonic cartilages (Fig. 2) , while type III collagen is not (von der Mark and von der Mark, 1977) . Second, the two promoters of the gene, which give rise to type III collagen mRNA or the alternative transcript, are active in different cell types (Zhang et al., 1997) .
Materials and methods

Antibody characterization
Antisera against synthetic peptides were affinity purified using the cognate peptides. Col3alt was cloned into pET23a(1) (Novagen) for expression in E. coli. Western blots containing 1 mg E. coli lysate expressing Col3alt or 40 mg chondrocyte lysate were incubated with antipeptide antibodies, followed by alkaline phosphatase-conjugated goat anti-rabbit IgG (Fisher). Blots were developed with NBT/ BCIP reagents (BioRad).
Immunofluorescence
Cultured cells were trypsinized and replated on dishes coated with poly-l-lysine (Pacifici et al., 1991) . Chick embryos and growth plates of 6-week-old chicken femurs Fig. 2 . Col3alt is present in cartilage, bone and muscle. All sections were incubated with 1280 Col3alt antibody (1:100) and goat anti-rabbit antibody conjugated to Alexafluor 568 (red fluorescence), unless otherwise indicated; similar results were obtained with 1256 antibody. (A-C), periorbital cartilage from 9-(A) and 13-(B,C) day-old embryos; (C) minus primary antibody; (D) Meckel's cartilage from 7-day-old embryo; (E) rib cartilage from 14-day-old embryo; (F) proximal femoral cartilage from 14-day-old embryo; (G-J) femoral growth plate from 6-week-old chicken incubated with 1280 anti-Col3alt (G), II116B3 anti-type II collagen (H), and 1280 anti-Col3alt and X-AC9 anti-type X collagen together (J); (I) phase contrast; (K) calvaria from 13-day-old embryo; (L-N) trabecular bone from sternum of 18-day-old embryo; (M) incubated in the presence of excess 1280 peptide; (N) minus primary antibody; (O,P,Q), pectoral muscle of 13-(O,P) and 18-(Q) day-old-embryo; (R), cross section of blood vessels; (P) minus primary antibody. All images except panels (G-J) are composites of immunofluorescence and phase contrast. The identity of the tissues in panels (O-R) as muscle was confirmed using titin antibody 9D10 (Wang and Greaser, 1985) and sarcomeric myosin antibody MF20 (Bader et al., 1982) (not shown). Type X collagen (Schmid and Linsenmayer, 1985) , myosin and titin antibodies were obtained from the Developmental Studies Hybridoma Bank; type II collagen antibody (Linsenmayer and Hendrix, 1980) was generously provided by Tom Linsenmayer. were embedded in TissueTek OCT (Electron Microscopy Sciences) and frozen at 280 8C. Ten-mm sections were treated with hyaluronidase and EDTA, fixed with zincformalin (Anatech), incubated with primary antibody, followed by secondary antibodies conjugated to Alexafluor 568 (red) or 488 (green) (Molecular Probes), and viewed with an Olympus Fluoview 2.1 confocal laser scanning microscope.
